March 29, 2025 01:12 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Telangana man marries two women in same ceremony after falling in love with both | Vladimir Putin says Russia won't interfere in Donald Trump's plans to 'take over' Greenland | India ready to offer possible assistance: PM Modi on Myanmar, Thailand earthquake | Magnitude 7.7 Earthquake hits Myanmar, strong tremors felt in Bangkok | 'Complete lawlessness': Suvendu Adhikari writes to Bengal Guv over Malda violence | 'You are a liar': Mamata Banerjee faces guests' ire over Singur, RG Kar, 'attack on Hindus' at London event | 3 cops killed, 2 terrorists shot dead during J&K's Kathua encounter: Report | Kolkata couple sues IVF centre for not revealing daughter's biological parents' identity, blames it for her death | 'India is not Dharamshala', Amit Shah says as Lok Sabha passes Immigration and Foreigners Bill 2025 | 'Now it's our turn': Vladimir Putin accepts Narendra Modi's invitation to visit India
CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

May 20, 2022, at 12:09 am

New Delhi: The Competition Commission of India (CCI) has approved the merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for the acquisition of approximately 15 percent equity shareholding of Biocon Biologics by Serum Institute Life Sciences.

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

May 04, 2021, at 05:09 pm

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.

Close menu